Retina Implant Lengthens Headstart In Subretinal Implant Market
This article was originally published in Clinica
Executive Summary
By CE-marking the Alpha AMS second-generation subretinal implant, Retina Implant has further widened the gap between itself and its rivals who are also developing devices to restore vision in patients blinded by degenerative retinal diseases such as retinitis pigmentosa.